In the past couple of weeks MFST has released multiple pieces of “game-changing” news. Now, after a couple of weeks of healthy trading the MFST chart looks amazing… we could see a breakout at any moment… even Barchart loves this chart right now giving it a high “Green” Opinion as we speak!
I really hope you’ve started your research on today’s New Pick MFST as it has the potential to be a Monster today. If not, there is still time, but get started right way:
- Late last month MFST, a young and rising biotech star, announced expanded development of its very cool laser technology devices that have been tested and proven to be efficacious against a wide variety of skin disorders. This new line of more versatile devices gives the Company a highly marketable product in a $4 Bln industry.
- Just days later MFST announced the acquisition of a chain of medical practices that specializes in the use of laser technologies. The chain has a known brand after years in operation on the east coast.
News has been a driving force for MFST recently; so much so that it has traded beautifully and built a gorgeous chart in the process. And we’re not the only ones who think so:
Check out Barchart’s Green Opinion with Indicators
In fact, take a look at all of the Indicators that are Green as we speak (provided by Barchart and StockTA):
Composite Indicators:
Trendspotter: Green
Short Term Indicators:
7 Day Average Directional Indicators: Green
20 Day Moving Average vs Price: Green
20 – 50 Day MACD Oscillator: Green
Exponential Moving Average: Very Bullish
Moving Average Convergence/Divergence: Very Bullish
High Analysis: Bullish
Medium Term Indicators:
50 Day Moving Average vs Price: Green
20 – 100 Day MACD Oscillator: Green
Exponential Moving Average: Very Bullish
Moving Average Convergence/Divergence: Very Bullish
Relative Strength Index: Bullish
Three Day Displaced Moving Average: Bullish
High Analysis: Very Bullish
Long Term Indicators
100 Day Moving vs Price: Green
Exponential Moving Average: Very Bullish
Moving Average Convergence/Divergence: Very Bullish
Now that is impressive. All of those traders who like technicals could love this one.
All of those who love biotech could as well… and then there’s the MJ crowd and the Ebola crowd… this play seems to have it all.
So consider the news. Consider the chart. Consider the milestones of this company and consider that it closed yesterday at just 3.4 cents!
Amazing… we could be in for something special:
Medifirst Solutions (MFST)
Company websites:
www.medifirstsolutions.com
www.medifirstusa.com
Quote:
www.otcmarkets.com/stock/MFST/quote
Opinion and Indicators:
www.barchart.com/opinions/stocks/MFST
Medifirst seeks innovative medical and healthcare products and technologies that are targeted to both medical and healthcare professionals as well as everyday consumers. MFST is developing and establishing both consumer and professional medical sector pipelines that will allow for the distribution of its new products and services.
At present the Company is a distributor for Botanical LED Light Therapy products, has instituted an anti-aging program in the Boca Med Spa in Boca Raton, Florida, is a dealer for Atmospheric Water Solutions, Inc. to sell water machines that make drinking water from air, has a computer IT remote support division, and has secured trademarks for magazines that would cover the legal cannabis market in Colorado and Florida.
The Company has a diverse product line including products for both consumers and professionals. At present time, they are focused on building products and affiliations in and related to:
- Health & Wellness Division
- Atmospheric Water Solutions
- Remote Technical Support
- Legal Med-MJ
They are developing products and programs in the anti-aging sector using laser technology as well as LED Light Therapy.
Through Medical Lasers Manufacturer Inc., a division of Medifirst Solutions, they have developed several unique mobile hand-held laser devices and a treatment protocol called The Time Machine Program designed for numerous anti-aging and skin care related applications.
Driven by the demand for anti-aging treatments and the growing importance of aesthetics, the global market for medical and therapeutic lasers have been estimated to grow as high as 4Bln Dlrs in 2015.
The Company recently announced the acquisition of a New Jersey based medical practice that specializes in anti-aging and cosmetic procedures. The practice has multiple locations and has been in business for 6-years.
CEO Bruce Schoengood commented, "This acquisition provides a wealth of benefits for Medifirst Solutions. In addition to an immediate positive financial impact, the acquisition expedites our expansion with our current anti-aging laser technology and Time Machine Program and provides a great synergy between both companies.”
The Health & Wellness market is extremely hot right now, and MFST is targeting some of the fastest growing segments in this market:
- In a research report by iData Research, the market for cosmetic plastic surgery, facial aesthetics and medical lasers is expected to almost double in size, exceeding 3Bln Dlrs by 2017.
- From the same report, the market for Botox injections is expected to grow an estimated 543Mln Dlrs by 2017.
- Juviderm and Restylane facial dermal fillers are also growing in the lucrative injectable filler market. iData’s report states that the U.S. market for aesthetic facial injectable products is valued at almost 860Mln Dlrs in 2010.
- The cosmeceutical industry is rapidly growing, with expected double-digit growth during the next 3 years.
- According to another research report by Transparency Market Research, in 2011, the global skincare devices market was valued at 5.4Bln USD and is expected to grow at a CAGR of 10.1% from 2012 to 2018, to reach an estimated value of 10.7Bln USD in 2018.
If ever there was a time to get excited… this is it! With products in many different markets the growth potential here is practically limitless.
Currently at just 3.4 cents even a slight move could translate to monstrous percentages.
With groundbreaking, innovative, biotech products that span three of the hottest industries on the small markets MFST could be on to something special.
We’ve never seen anything like it. The possibilities are awesome.
So get started on researching this exciting young biotech right away. The sky could be the limit.
Remember, we always encourage you to do further research. Never take our word for it, read our disclaimer to see why, and of course always consult a professional.
Just because a situation looks great things can still go wrong and often do. Be smart and protect yourself.
Enjoy your morning,
RB
IMPORTANT NOTICE AND DISCLAIMER
This is a paid email ad for the company or companies mentioned herein. This paid advertisement does not provide an analysis of any company's financial position, operations or prospects and as such this is not to be construed as a recommendation or a solicitation to buy or sell any security. Do not base any investment and/or financial decisions upon any of the materials found on our website or in our newsletter publication(s) such as this one. Market365, LLC, the publisher of this newsletter and the website(s) associated with this email publication and its affiliates and contractors are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever and we are not qualified to give financial advice
Our full disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list: Full Disclaimer
Release of Liability: Through use of this newsletter or viewing or using our website(s), you agree to hold Market365, its operators, owners, employees and/or contractors harmless and to completely release them from any and all liability due to any and all losses (monetary or otherwise), damages (monetary or otherwise) that may occur and/or that you may incur.
This is a paid email campaign: Market365 and its employees are not a Registered Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever and we are not qualified to give financial advice. Market365 is a media and advertising firm that is often compensated by the companies profiled in our newsletter(s) and/or on our website(s). Compensation is received in cash via bank wire. We never receive compensation in shares. All compensation is disclosed in our newsletter(s) and/or on our website(s).
Compensation: We have received three thou.sand seven hundred and fifty dollars by a third party, ACN LLC, for this marketing campaign of Medifirst Solutions. All compensation is received via bank wire. We do not own any shares or hold any positions in Medifirst Solutions.
Conflict of Interest: We do not investigate the background of any third party. The third party may have shares and may liquidate them, which may negatively affect the stock price. The above compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company.
Forward looking statements: The Private Securities Litigation Reform Act of 1995 provides investors a 'safe harbor' in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance that are not statements of historical fact may be "forward looking statements". Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks an uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as "projects", "foresee", "expects", "will", "anticipates", "estimates", "believes", "understands", or that by statements indicating certain actions "may", "could", or "might" occur. Understand there is no guarantee past performance will be indicative of future results.
Information: Market365 is committed to providing factual information on the companies that are profiled. However, we do not provide any assurances as to the accuracy or completeness of the information provided, including information regarding a profiled company's plans or ability to effect any planned or proposed actions. Market365 has no first-hand knowledge of any profiled company's operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so. Statistical information, dollar amounts, and market size data was provided by the subject company and related sources which we believe to be reliable. To the fullest extent of the law, Market365 will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the alert, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information).
Third Party Websites: This email may provide hyperlinks to third party websites or access to third party content. Market365, its owners, officers, directors, contractors and employees are not responsible for errors and omissions nor does Market365 control, endorse, or guarantee any content found in such sites. By accessing, viewing, or using the website or communications originating from this release, you agree that Market365, its owners, officers, directors, contractors and employees, are not responsible for any content, associated links, resources, or services associated with a third party website. You further agree that Market365, its owners, officers, directors, contractors and employees shall not be liable for any loss or damage of any sort associated with your use of third party content. Links and access to these sites are provided for your convenience only.
This email is based entirely upon information gathered from public information. Although the information contained in this e-mail is believed to be reliable, Market365 makes no warranties as to the accuracy of the content of this e-mail, expressly disclaims and accepts no liability for how readers may choose to utilize the content of this e-mail. Market365 does not verify the validity of any press releases in this electronic communication. Readers are strongly urged to independently verify all statements made in this email and to perform their own due diligence on this or any other advertised company, including but not limited to consulting with a qualified investment professional, reviewing the publicly available financial statements of, and other information about these featured companies and verifying that an investment in that company is appropriate and suitable for you.
Many companies have filed information with state securities regulators and many companies will supply prospective investors with additional information upon request. We encourage you to invest carefully and read investment information available at the websites of the SEC at www.sec.gov and FINRA at www.finra.org.
